326
|
Gale GR, Howle JA, Smith AB. Chemical and bacteriological studies of the photochemical reaction product of ammonium hexachloroiridate. IV. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE. SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (NEW YORK, N.Y.) 1970; 135:690-4. [PMID: 4922353 DOI: 10.3181/00379727-135-35122] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
327
|
Gale GR, Hynes JB, Smith AB. Synthesis of additional arylhydroxamic acids wich inhibit nucleic acid biosynthesis in vitro. J Med Chem 1970; 13:571-4. [PMID: 5466756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
328
|
Gale GR, Hynes JB, Smith AB. Synthesis of additional arylhydroxamic acids which inhibit nucleic acid biosynthesis in vitro. J Med Chem 1970; 13:571-4. [PMID: 5466874] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
329
|
|
330
|
Gale GR, Smith AB, Walker EM. Selective inhibition by sorbylhydroxamic acid of deoxyribonucleic acid synthesis in Ehrlich ascites tumor cells. Cancer Res 1970; 30:24-9. [PMID: 5441077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
331
|
|
332
|
|
333
|
Gale GR, Smith AB. Alanosine and hadacidin--comparison of effects on adenylosuccinate synthetase. Biochem Pharmacol 1968; 17:2495-8. [PMID: 4888630 DOI: 10.1016/0006-2952(68)90144-5] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
334
|
|
335
|
Gale GR, Smith AB, Hynes JB. Hydroxyurea derivatives: 1-hydroxybiuret and 3-hydroxybiuret. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE. SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (NEW YORK, N.Y.) 1968; 127:1191-6. [PMID: 5690321 DOI: 10.3181/00379727-127-32907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
336
|
Gale GR, Smith AB. Effects of certain hydroxamic acids on virus replication. EXPERIENTIA 1968; 24:194-5. [PMID: 4868479 DOI: 10.1007/bf02146984] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
337
|
Lister D, Smith AB, Dunford C. Fast-Neutron Scattering from the 182, 184, and 186 Isotopes of Tungsten. ACTA ACUST UNITED AC 1967. [DOI: 10.1103/physrev.162.1077] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
338
|
Gale GR, Simpson JG, Smith AB. Studies of the mode of action of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide. Cancer Res 1967; 27:1186-91. [PMID: 4952509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
339
|
Smith AB. An anatomical problem of the surgical treatment of otosclerosis. Proc R Soc Med 1966; 59:229-35. [PMID: 5909763 PMCID: PMC1900776] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
340
|
De Villiers JAM, Engelbrecht CA, Vonach WG, Smith AB. Neutron scattering from Au, Hg, and Tl. ACTA ACUST UNITED AC 1965. [DOI: 10.1007/bf01380762] [Citation(s) in RCA: 30] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
341
|
|
342
|
Friedman AM, Meadows JW, Smith AB, Fields PR, Milsted J, Whalen JF. Fission Fragment Kinetic Energies ofCf246,Cf248, andCf254. ACTA ACUST UNITED AC 1963. [DOI: 10.1103/physrev.131.1203] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
343
|
Smith AB. 1960 Nuclear Data Tables; Part 4, Short Tables. NUCL SCI ENG 1963. [DOI: 10.13182/nse63-a26490] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
344
|
|
345
|
|
346
|
|
347
|
Smith AB, Fields PR, Friedman AM. Prompt Gamma Rays Accompanying the Spontaneous Fission ofCf252. ACTA ACUST UNITED AC 1956. [DOI: 10.1103/physrev.104.699] [Citation(s) in RCA: 53] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
348
|
|
349
|
Barnes LA, Cooper ML, Jerome EA, Durant RC, Smith AB. Field Trial of Shigella Flexneri III Vaccine. THE JOURNAL OF IMMUNOLOGY 1951. [DOI: 10.4049/jimmunol.66.5.515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Summary
Mouse protective tests were conducted with serums taken from 633 officers and men aboard five cruisers before inoculation with Shigella flexneri III vaccines and from different groups at eight postinoculation intervals; a control group that received placebos only was included. Statistical evaluations of the data were made to obtain evidence concerning the efficacy of the vaccines employed. Statistically significant antibody responses were observed in serums from two groups of men who had received primary subcutaneous inoculations of S. flexneri III vaccine; fold increases were 9.2 and 10.5. Little or no enhancement in protective power of serums was obtained by oral administration of S. flexneri III vaccine. The peak of protective antibody production following parenteral inoculations was reached approximately three weeks after the last injection in the initial course of vaccine. Evidence was obtained that indicated the persistence of a statistically significant amount of circulating antibody for approximately six months. Previous epidemiologic experiences of men with S. flexneri III apparently influenced their antibody response to artificial parenteral stimulation with vaccine. Preinoculation antibody levels differed significantly depending upon whether individuals had been present and ill, present but not ill, or not present in an epidemic. Those who had reported clinical symptoms possessed the highest titers and serums from men with no prior contact showed the lowest antibody content. Protective antibody levels after inoculation were, however, of a similar order in the three groups. It appeared, therefore, that there was a point beyond which antibody formation could not be increased by the stimulus applied regardless of the initial antibody level. A single subcutaneous booster dose of S. flexneri III vaccine administered to a group of men six months after the initial inoculations increased only slightly the mouse protective power of the serums. This lack of further antibody response following the recall dose was probably due to the persistence of antibody levels that could not be elevated markedly by the additional antigen injected. It appeared that the parenterally administered S. flexneri III vaccine induced the production of protective antibody in susceptible individuals to a degree comparable with that found in men who had experienced a natural infection. Records suggest that persons who have convalesced from the disease rarely suffer second attacks due to the same Shigella type.
Collapse
|
350
|
Smith AB. The Record and the Metric System. Science 1946; 103:634. [PMID: 17808414 DOI: 10.1126/science.103.2681.634-c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|